v3.24.3
Consolidated Statements of Operations (unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Digital mining revenues $ 1,127,455 $ 3,283,473 $ 8,618,436 $ 8,342,646
Specialty finance revenue 97,558 101,535 303,222 474,544
Rental revenue 30,460 34,500 92,766 111,486
Total revenues 1,255,473 3,419,508 9,014,424 8,928,676
Operating costs and expenses:        
Digital mining cost of revenues (exclusive of depreciation and amortization shown below) 730,716 2,708,473 5,742,773 6,737,971
Depreciation and amortization 2,349,634 1,516,873 7,115,404 3,487,866
Gain on fair value of Bitcoin, net (104,744)   (3,096,774)  
Impairment loss on mining equipment 0   1,188,058 0
Impairment loss on mined digital assets   383,497   822,650
Realized gain on sale of mined digital assets   (261,191)   (1,331,982)
Professional fees 628,686 419,173 1,622,914 1,228,503
Selling, general and administrative 209,088 201,151 582,675 683,174
Real estate management and disposal 31,144 26,453 89,430 127,611
Collection costs 15,054 8,098 36,396 17,533
Settlement costs with associations       10,000
Loss on disposal of assets 12,449   54,506 0
Other operating costs 229,784 246,735 667,401 704,589
Total operating costs and expenses 5,669,795 6,589,927 17,651,681 17,224,855
Operating loss (4,414,322) (3,170,419) (8,637,257) (8,296,179)
Unrealized gain (loss) on marketable securities (3,296) 2,058 984 6,436
Impairment loss on prepaid machine deposits (12,941)   (12,941) (36,691)
Unrealized loss on investment and equity securities (346,866) (778,078) (852,624) (10,317,613)
Impairment loss on Symbiont assets   (750,678)   (750,678)
Gain on fair value of purchased Bitcoin, net     57,926  
Realized gain on securities   1,788   1,788
Realized gain on sale of purchased digital assets       1,917
Credit loss on Seastar Medical Holding Corporation notes receivable   (22,344)   (22,344)
Gain on adjustment of note receivable allowance       1,052,543
Other income - coupon sales   10,160 4,490 639,472
Other income - financing revenue       37,660
Interest expense (124,035)   (231,754)  
Interest income 98,343 39,657 124,696 210,881
Loss before income taxes (4,803,117) (4,667,856) (9,546,480) (17,472,808)
Income tax expense 0 0 0 0
Net Loss (4,803,117) (4,667,856) (9,546,480) (17,472,808)
Less: loss attributable to non-controlling interest 105,043 250,880 265,296 3,120,321
Net loss attributable to LM Funding America Inc. (4,698,074) (4,416,976) (9,281,184) (14,352,487)
Less: deemed dividends (Note 8) (1,704,305)   (1,704,305)  
Net loss attributable to common shareholders $ (6,402,379) $ (4,416,976) $ (10,985,489) $ (14,352,487)
Basic loss per common share (Note 1) $ (2.41) $ (1.97) $ (4.35) $ (6.51)
Diluted loss per common share (Note 1) $ (2.41) $ (1.97) $ (4.35) $ (6.51)
Weighted average number of common shares outstanding:        
Basic 2,659,974 2,246,745 2,525,160 2,206,187
Diluted 2,659,974 2,246,745 2,525,160 2,206,187
Service [Member]        
Operating costs and expenses:        
Staff costs and payroll $ 1,567,984 $ 1,340,665 $ 3,648,898 $ 4,736,940

Source

HTML PDF
ZIP